The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Transverse myelitis:Genomics, Cell Biology, Clinical Manifestations, Diagnosis, Treatment, and Long-Term Prognosis

Author: John Murphy, CEO, The COVID-19 Long Haul Foundation Abstract Background Transverse myelitis (TM) is an uncommon inflammatory disorder of the spinal cord characterized by acute or subacute neurological dysfunction […]

Multidisciplinary Care Pathways for Long COVID Fatigue:

A Systems-Based Model Integrating Rehabilitation Medicine, Neuroimmunology, Autonomic Care, and Precision Phenotyping Abstract Background Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one […]

Persistent SARS-CoV-2 Reservoirs and the Pathobiology of Long COVID

Etiology, Tissue Persistence, Genomics, Clinical Manifestations, Biomarkers, and Emerging Therapeutic Strategies John Murphy, Chief Executive Officer, The COVID-19 Long-haul Foundation Abstract Background More than four years after the emergence of […]

Long COVID and Persistent Pulmonary Dysfunction: Emerging Evidence for Chronic Respiratory Sequelae, Pulmonary Pathology, and Dyspnea

John Murphy, President COVID-19 Long-haul Foundation Abstract Long COVID, also termed post-COVID condition or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to represent one of the most consequential chronic disease […]